Adrenal Hypoplasia Congenita Presenting as Congenital Adrenal Hyperplasia

We report on a patient with genetically confirmed adrenal hypoplasia congenita (AHC) whose presentation and laboratory abnormalities were consistent with the more common condition, congenital adrenal hyperplasia (CAH). The patient presented with failure to thrive and salt wasting. General appearance...

Full description

Saved in:
Bibliographic Details
Main Authors: Jennifer L. Flint, Jill D. Jacobson
Format: Article
Language:English
Published: Wiley 2013-01-01
Series:Case Reports in Endocrinology
Online Access:http://dx.doi.org/10.1155/2013/393584
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832564681680617472
author Jennifer L. Flint
Jill D. Jacobson
author_facet Jennifer L. Flint
Jill D. Jacobson
author_sort Jennifer L. Flint
collection DOAJ
description We report on a patient with genetically confirmed adrenal hypoplasia congenita (AHC) whose presentation and laboratory abnormalities were consistent with the more common condition, congenital adrenal hyperplasia (CAH). The patient presented with failure to thrive and salt wasting. General appearance showed marked hyperpigmentation and normal male genitalia. He displayed mildly elevated 17-hydroxyprogesterone and markedly elevated 11-deoxycortisol levels at baseline and with ACTH stimulation testing. Results were consistent with 11β-hydroxylase deficiency. He required glucocorticoids and high doses of mineralocorticoids. The marked elevation in 11-deoxycortisol directed our clinical reasoning away from a hypoplastic condition and towards a hyperplasic adrenal condition. Sequencing of the DAX1 gene (named for dosage-sensitive sex reversal (DSS) locus and the AHC locus on the X chromosome) revealed a missense mutation. A review of the literature revealed that elevated 11-deoxycortisol levels have been noted in kindreds with DAX1 mutations, but only when measured very early in life. A mouse model has recently been described that displays elevated 11-deoxycorticosterone levels and evidence for hyperplasia of the zona glomerulosa of the adrenal gland. We conclude that DAX1 testing may be considered in patients with laboratory evidence of 11β-hydroxylase deficiency, especially in those with severe salt wasting.
format Article
id doaj-art-496cc2e47839457cb828291b591bd5b6
institution Kabale University
issn 2090-6501
2090-651X
language English
publishDate 2013-01-01
publisher Wiley
record_format Article
series Case Reports in Endocrinology
spelling doaj-art-496cc2e47839457cb828291b591bd5b62025-02-03T01:10:28ZengWileyCase Reports in Endocrinology2090-65012090-651X2013-01-01201310.1155/2013/393584393584Adrenal Hypoplasia Congenita Presenting as Congenital Adrenal HyperplasiaJennifer L. Flint0Jill D. Jacobson1Department of Pediatrics, Children's Mercy Hospitals and Clinics, University of Missouri-Kansas City School of Medicine, Kansas City, MO 64108, USADivision of Endocrinology and Diabetes, Children's Mercy Hospitals and Clinics, University of Missouri-Kansas City School of Medicine, Kansas City, MO 64108, USAWe report on a patient with genetically confirmed adrenal hypoplasia congenita (AHC) whose presentation and laboratory abnormalities were consistent with the more common condition, congenital adrenal hyperplasia (CAH). The patient presented with failure to thrive and salt wasting. General appearance showed marked hyperpigmentation and normal male genitalia. He displayed mildly elevated 17-hydroxyprogesterone and markedly elevated 11-deoxycortisol levels at baseline and with ACTH stimulation testing. Results were consistent with 11β-hydroxylase deficiency. He required glucocorticoids and high doses of mineralocorticoids. The marked elevation in 11-deoxycortisol directed our clinical reasoning away from a hypoplastic condition and towards a hyperplasic adrenal condition. Sequencing of the DAX1 gene (named for dosage-sensitive sex reversal (DSS) locus and the AHC locus on the X chromosome) revealed a missense mutation. A review of the literature revealed that elevated 11-deoxycortisol levels have been noted in kindreds with DAX1 mutations, but only when measured very early in life. A mouse model has recently been described that displays elevated 11-deoxycorticosterone levels and evidence for hyperplasia of the zona glomerulosa of the adrenal gland. We conclude that DAX1 testing may be considered in patients with laboratory evidence of 11β-hydroxylase deficiency, especially in those with severe salt wasting.http://dx.doi.org/10.1155/2013/393584
spellingShingle Jennifer L. Flint
Jill D. Jacobson
Adrenal Hypoplasia Congenita Presenting as Congenital Adrenal Hyperplasia
Case Reports in Endocrinology
title Adrenal Hypoplasia Congenita Presenting as Congenital Adrenal Hyperplasia
title_full Adrenal Hypoplasia Congenita Presenting as Congenital Adrenal Hyperplasia
title_fullStr Adrenal Hypoplasia Congenita Presenting as Congenital Adrenal Hyperplasia
title_full_unstemmed Adrenal Hypoplasia Congenita Presenting as Congenital Adrenal Hyperplasia
title_short Adrenal Hypoplasia Congenita Presenting as Congenital Adrenal Hyperplasia
title_sort adrenal hypoplasia congenita presenting as congenital adrenal hyperplasia
url http://dx.doi.org/10.1155/2013/393584
work_keys_str_mv AT jenniferlflint adrenalhypoplasiacongenitapresentingascongenitaladrenalhyperplasia
AT jilldjacobson adrenalhypoplasiacongenitapresentingascongenitaladrenalhyperplasia